Device maker TriVascular Technologies plans an IPO in hopes of raising as much as $100 million to repay Boston Scientific, build up sales & marketing and fund additional R&D.
California medical device maker TriVascular Technologies is looking to raise as much as $100 million through its initial public offering, the details of which have yet to be finalized.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1fn5F7E
Cap comentari:
Publica un comentari a l'entrada